Literature DB >> 8076423

Renin and angiotensin-converting enzyme genotypes in patients with essential hypertension and left ventricular hypertrophy.

M J West1, K M Summers, D J Burstow, K K Wong, P R Huggard.   

Abstract

1. The associations between left ventricular hypertrophy (LVH) and specific alleles of the renin and angiotensin-converting enzyme (ACE) genes were studied in patients with essential hypertension and normal blood pressure. 2. LVH was present in 42% of those with essential hypertension (n = 72) and 17% of those with normal blood pressure (n = 44). 3. The frequency of each renin allele was the same in hypertensive and in normotensive patients. Renin allele frequencies were also the same for those with LVH and those with normal cardiac mass. When only hypertensives were considered, renin alleles were in the same proportion for the groups with and without LVH. Similarly, ACE alleles were not associated with essential hypertension nor with elevated cardiac mass. 4. We conclude that, in this population, variations in the renin or ACE genes do not contribute significantly to the development of LVH or to essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8076423     DOI: 10.1111/j.1440-1681.1994.tb02497.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  3 in total

1.  Angiotensin-converting enzyme gene deletion allele increases the risk of left ventricular hypertrophy: evidence from a meta-analysis.

Authors:  Xiaobo Li; Yuqiong Li; Nan Jia; Shujie Guo; Shaoli Chu; Wenquan Niu
Journal:  Mol Biol Rep       Date:  2012-07-07       Impact factor: 2.316

Review 2.  Cardiovascular disease and genetics of the renin-angiotensin system.

Authors:  S B Harrap
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

3.  Renin gene polymorphisms in bangladeshi hypertensive population.

Authors:  Rownock Afruza; Laila N Islam; Sajal Banerjee; Md Mahbub Hassan; Fumiaki Suzuki; Ahm Nurun Nabi
Journal:  J Genomics       Date:  2014-02-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.